Abstract | BACKGROUND: METHODS: 121 mutation-negative probands were screened for rearrangements in SPG4 by multiplex ligation-dependent probe amplification. RESULTS: 24 patients with 16 different heterozygotic exon deletions in SPG4 (20%) were identified, ranging from one exon to the whole coding sequence. Comparison with 78 patients with point mutations showed a similar clinical picture but an earlier age at onset. CONCLUSIONS: Exon deletions in SPG4 are as frequent as point mutations, and SPG4 is responsible for 40% of AD-HSP.
|
Authors | Christel Depienne, Estelle Fedirko, Sylvie Forlani, Cécile Cazeneuve, Pascale Ribaï, Imed Feki, Chantal Tallaksen, Karine Nguyen, Bruno Stankoff, Merle Ruberg, Giovanni Stevanin, Alexandra Durr, Alexis Brice |
Journal | Journal of medical genetics
(J Med Genet)
Vol. 44
Issue 4
Pg. 281-4
(Apr 2007)
ISSN: 1468-6244 [Electronic] England |
PMID | 17098887
(Publication Type: Comparative Study, Letter, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adenosine Triphosphatases
- Spastin
- SPAST protein, human
|
Topics |
- Adenosine Triphosphatases
(deficiency, genetics)
- Adolescent
- Adult
- Age of Onset
- Aged
- Child
- Child, Preschool
- DNA Mutational Analysis
- Exons
(genetics)
- Female
- France
(epidemiology)
- Genetic Heterogeneity
- Genetic Testing
- Humans
- Infant
- Male
- Middle Aged
- Point Mutation
- Polymerase Chain Reaction
(methods)
- Portugal
(epidemiology)
- Spain
(epidemiology)
- Spastic Paraplegia, Hereditary
(epidemiology, genetics)
- Spastin
|